RheoSCAN

Early diagnosis of Diabetic complications and Metabolic syndrome

diabetic complication early diagnosis rheoscan

Early Diagnosis of Diabetic Nephropathy

What are the symptoms?

  • No apparent symptoms at early stages

  • Usually appear when kidney damage to progress

  • Even then, symptoms tend to be vague

​Who is at risk?

  • All people with diabetes – both type 1 and type 2 –  are at risk

What is Diabetic Nephropathy?

  • About 25% with diabetes eventually develops diabetic nephropathy (diabetic kidney disease)

  • Diabetic nephropathy is a leading cause of kidney failure, requiring hemodialysis.

  • Local hypertension

  • Low filtration rate

  • Proteins in urine

rheomeditech diabetic nephropathy early diagnosis rheoscan

RheoScan CSS

  • RBC Critical Shear Stress(CSS) shows high correlation with nephropathy in T2DM

  • RheoScan-CSS can screen diabetic nephropathy among type 2 diabetic patients

*Patient who should be excluded 
Arthritis patient, Person who drank alcohol within 48 hours, Iron deficiency anemia, Pulmonary thrombosis, Artificial Heart, Malaria

Diabetes Mellitus

Diabetic Complications

Decision supporting system for precision test

Patients with DM have hyperglycemia and elevated fibrinogen that leads to impaired RBC deformability and aggregation

Alteration of deformability and aggregation of RBCs can be detected with RheoScan system at earlier stages of diabetic complications

Diabetic Kidney Disease (DKD) Screening Assay

CSS shows significantly high correlation with diabetic kidney diseases classified by either ACR or GFR.

eGFR Rheoscan

In the ROC curve analysis with eGFR (AUC = 0.615),

- sensitivity 60.3%

- specificity: 59.6%

- Odd ratio: 2.573 (95% CI = 1.057–6.264, p < 0.05)

Odd ratio; difference between CSS T1 and T3 is 2.573 

RheoSCAN for diabetic compliations and Metabolic syndrome eGFR
Rheoscan uACR DKD

In the ROC curve analysis with uACR (AUC = 0.635)

- sensitivity: 60.2%

- specificity: 60.3%

- Odd ratio: 3.063 (95% = CI 1.632–5.748, p < 0.01)

Odd ratio; difference between CSS T1 and T3 is 3.063 

RheoSCAN for diabetic compliations and Metabolic syndrome uACR

Reference*

Chung et al., Critical Shear Stress is Associated with Diabetic Kidney Disease in Patients with Type 2 Diabetes, Scientific Reports (2018) 8:908

RheoSCAN for diabetic compliations and Metabolic syndrome GFR

Critical Shear Stress can detect early stages  diabetic complications.

 

CSS shows significant difference between Healthy group(RED) and Patients with diabetic complications group(GREEN).

CSS can detect Diabetic complications from diabetic patients  at GFR 3 or ACR 2.  who do not have any symptoms.

rheomeditech rheoscan Diabetic Mellitus complication
rheomeditech rheoscan diagnosis Diabetic Mellitus complication

Reference*

Gyawali et al., Hemorheology, ankle brachial pressure index (ABPI) and toe brachial pressure index (TBPI) in metabolic syndrome, Microvascular research 95 (2014), 31-36

Gyawali et al., Hemorheological parameters better classify metabolic syndrome than novel cardiovascular risk factors and peripheral vascular disease marker, Clin. hemorheol. microcirc. 64 (2016), 1-5

Early Diagnosis of Diabetic Retinopathy

What is T2DM Diabetic Retinopathy? 

  • It is the most common diabetic eye complication and the leading cause of blindness in working age people.

  • Retinopathy causes vision loss in either macular edema or proliferative diabetic retinopathy

What are the symptoms?

  • Diabetic Retinopathy can be destroying the eye's blood vessels without any noticeable symptoms

Who is at risk?

  • All people with diabetes - both type1 and type2 - are at risk

RBC deformability reduction shows high correlation with retinopathy in T2DM.

RheoScan-D predicts diabetic retinopathy among type 2 diabetic patients.

rheomeditech diabetic retinopathy early diagnosis rheoscan
rheomeditech diabetic retinopathy early diagnosis rheoscan

RBC deformability reduction indicates 2.93 folds high risk to have diabetic to have diabetic retinopathy in T2DM.

Early detection of Metabolic Syndrome

Metabolic syndrome performance rheoscan
metabolic syndrome performance rheoscan.

In the ROC curve analysis,

- AUC of CSS is 0.818

(95% CI: 0.715 to 0.922, P < 0.0005)

- Odd ratio for predicting metabolic syndrome by CSS is 3.896   (95% CI: 2.174 to 6.985, P < 0.0005)

Use of RBC deformability index as an early marker of diabetic nephropathy 

Hemorheological Approach for Early Detection of Chronic Kidney Disease and Diabetic Nephropathy in Type 2 Diabetes

Progressive impairment of erythrocyte deformability as indicator of microangiopathy in type 2 diabetes mellitus

Hemorheology and clinical application : association of impairment of red blood cell deformability with diabetic nephropathy

Critical Shear Stress is Associated with Diabetic Kidney Disease in Patients with Type 2 Diabetes

Potential Diagnostic Hemorheological Indexes for Chronic Kidney Disease in Patients With Type 2 Diabetes

Hemorheology, ankle brachial pressure index (ABPI) and toe brachial pressure index (TBPI) in metabolic syndrome

Association of altered hemorheology with oxidative stress and inflammation in metabolic syndrome

The association of dyslipidemia with erythrocyte aggregation

Hemorheological parameters better classify metabolic syndrome than novel cardiovascular risk factors and peripheral vascular disease marker

Erythrocyte aggregation and metabolic syndrome

Please see our latest catalog for any updates! (Menu bar → Download ) 

Send us an email directly to us for any inquires about research, clinical trials. 

RheoScan Product Catalog  (2021.03)